Brief: Newbury Pharmaceuticals Secures Approval For Varenicline In Sweden
Sept 23 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* SECURES APPROVAL FOR VARENICLINE IN SWEDEN
* APPROVAL IN ICELAND IS EXPECTED TO FOLLOW UPON FINALIZED
NATIONAL REVIEW
Source text for Eikon: ID:nMFNc6MSmr
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln